Merck said that a phase-three study of its pulmonary arterial hypertension treatment met its primary endpoints.

In this review, we discuss and evaluate the rigor of the preclinical data that support the notion that 22 medications could potentially be used to target molecular mechanisms involved in the ...

For losartan, plasma renin activity and Ang II increases were ... Male and female patients (aged 21 to 70 years) with mild to moderate hypertension (supine diastolic blood pressure, 95 to 110 mm Hg ...